5 Reasons Why Moderna Stock Jumped 170% and How Far It Can Go
Moderna (MRNA) jumped 177% on Wednesday, and the strangest part is how little news it took. A $200 million estimate change moved $30 billion on the stock market. Moderna became famous for its COVID vaccine five years ago, and its stock price is now at its highest since mid-2024. So, investors wasted no time taking profits after such a massive rally. But can the stock price climb further? Or will the rally stop here? Sponsored Sponsored What Actually Made Moderna Jump 130%? The drug did not do it alone. Leerinks revised estimate raised its 2032 sales estimate by roughly $200 million. Yet, the stock moved 150 times that amount in a market already at record highs. The 150x Gap: BeInCrypto Five loaded conditions did the rest. Moderna had collapsed 95% from $484 to $22. The recovery was already running, up 357% in 2026 on a flu approval before the cancer news. Modernas Collapse Came First: BeInCrypto The price sat above all six moving averages while analysts refused to believe with a $52.95 average target under the current price. Bearish MRNA Analysts: TipRanks And short sellers, traders who borrow shares and sell them betting on a fall, held 13.37% short interest in the freely traded shares, losing $4.8 billion when the readout